FUTUREMEDS LTD
Get an alert when FUTUREMEDS LTD files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2026-05-30 (this month)
Last made up 2025-05-16
Watchouts
Cash
£3M
+205.9% vs 2023
Net assets
£6M
+42.3% highest in 5 filed years
Employees
397
+38.3% highest in 5 filed years
Profit before tax
£2M
+35% vs 2023
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
4 officer resignations in last 12 months
Multiple officers have left the board recently — see the People section for who.
Net assets
5-year trend · vs Industrials median
Accounts
5-year trend · latest reflected 2024-12-31
| Metric | Trend | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Turnover | — | — | — | £15,579,961 | £26,966,653 | |
| Operating profit | — | — | — | £1,951,624 | £3,347,146 | |
| Profit before tax | — | — | — | £1,326,018 | £1,790,037 | |
| Net profit | — | — | — | £1,730,660 | £1,782,992 | |
| Cash | £603,415 | £2,745,627 | £1,008,559 | £861,858 | £2,636,122 | |
| Total assets less current liabilities | £1,494,256 | £3,855,786 | £2,665,610 | £11,367,340 | £14,176,723 | |
| Net assets | £1,222,104 | £1,936,881 | £554,815 | £4,123,371 | £5,868,863 | |
| Equity | — | — | — | £4,123,371 | £5,868,863 | |
| Average employees | 1 | 3 | 18 | 287 | 397 | |
| Wages | — | — | — | £7,386,784 | £13,374,701 | |
| Directors' remuneration | £27,500 | £57,500 | £60,549 | £60,000 | £60,000 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
+73.1%
£15,579,961 £26,966,653
-
Cash
+205.9%
£861,858 £2,636,122
-
Net assets
+42.3%
£4,123,371 £5,868,863
highest in 5 filed years
-
Employees
+38.3%
287 397
highest in 5 filed years
-
Operating profit
+71.5%
£1,951,624 £3,347,146
-
Profit before tax
+35%
£1,326,018 £1,790,037
-
Wages
+81.1%
£7,386,784 £13,374,701
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Operating margin | — | — | — | 12.5% | 12.4% | |
| Net margin | — | — | — | 11.1% | 6.6% | |
| Return on capital employed | — | — | — | 17.2% | 23.6% | |
| Gearing (liabilities / total assets) | — | — | — | 77.7% | 77.1% | |
| Current ratio | — | — | — | 0.99x | 1.17x | |
| Interest cover | — | — | — | 3.00x | 2.11x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- IFRS
- Reporting scope
- Consolidated group
- Auditor
- Forvis Mazars LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The Directors are satisfied that the Group has adequate resources to continue in operational existence for the foreseeable future. Accordingly, the Directors continue to adopt the going concern basis in preparing the consolidated financial statements.”
Group structure
- FUTUREMEDS LTD · parent
- FutureMeds sp. z o.o. 100%
- Evidence Based Medicine and Good Clinical Practice Research Institute 100%
- Private Small-Scale Enterprise Medical Center "Pulse" 100%
- Medical Center FutureMeds EOOD 100%
- "Diagnostic and Consultative Center Ascendent" OOD 100%
- emovis GmbH 100%
- FutureMeds Spain S.L. 100%
- Community Pharmacology Services Limited 100%
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
3 active · 4 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| CHAMBERS, Paul Michael | Director | 2020-06-01 | Aug 1979 | British |
| JANIAK, Radoslaw | Director | 2020-04-17 | Nov 1972 | Polish |
| MADDISON, Paul | Director | 2026-04-10 | May 1977 | British |
Show 4 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BERTHOUX, Christophe, Dr | Director | 2020-06-15 | 2025-07-23 |
| GONDEK, Marcin | Director | 2020-03-17 | 2026-04-10 |
| GOULD, Gerard | Director | 2021-08-21 | 2025-07-23 |
| HANNIGAN, Chris | Director | 2020-06-15 | 2025-07-23 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Futuremeds Bidco Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2025-07-23 | Active |
| Mr Marcin Gondek | Individual | Significant influence | 2020-03-17 | Ceased 2024-01-01 |
| Mr Marcin Gondek | Individual | Shares 25–50%, Voting 25–50%, Appoints directors | 2020-03-17 | Ceased 2021-08-20 |
| Dr Radoslaw Janiak | Individual | Shares 25–50%, Voting 25–50%, Appoints directors | 2020-03-17 | Ceased 2021-08-20 |
Filing timeline
Last 20 of 61 total filings
Material constitutional events — rename, articles re-file, resolution
- 2025-09-15 RESOLUTIONS Resolution
- 2025-09-15 RESOLUTIONS Resolution
- 2025-08-01 RESOLUTIONS Resolution
- 2025-08-01 MA Memorandum articles
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-05-05 | TM01 | officers | Termination director company with name termination date | |
| 2026-04-13 | AP01 | officers | Appoint person director company with name date | |
| 2025-11-11 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2025-11-07 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2025-11-05 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2025-11-05 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2025-11-04 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2025-10-31 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2025-09-15 | RESOLUTIONS | resolution | Resolution | |
| 2025-09-15 | RESOLUTIONS | resolution | Resolution | |
| 2025-08-15 | SH02 | capital | Capital alter shares subdivision | |
| 2025-08-15 | SH02 | capital | Capital alter shares subdivision | |
| 2025-08-13 | SH02 | capital | Capital alter shares subdivision | |
| 2025-08-13 | SH08 | capital | Capital name of class of shares | |
| 2025-08-01 | RESOLUTIONS | resolution | Resolution | |
| 2025-08-01 | MA | incorporation | Memorandum articles | |
| 2025-07-31 | SH08 | capital | Capital name of class of shares | |
| 2025-07-30 | PSC02 | persons-with-significant-control | Notification of a person with significant control | |
| 2025-07-30 | TM01 | officers | Termination director company with name termination date | |
| 2025-07-30 | TM01 | officers | Termination director company with name termination date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 20
- Capital events
- 5
- Officers appointed
- 1
- Officers resigned
- 4
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.